ClinicalTrials.Veeva

Menu

Assessment of Measurement Variability Across Automated Biometry Devices

B

Berkeley Eye Center

Status

Completed

Conditions

Myopia

Treatments

Diagnostic Test: Argos
Diagnostic Test: IOL Master 500
Diagnostic Test: Pentacam
Diagnostic Test: Orbscan II
Diagnostic Test: Atlas 9000
Diagnostic Test: Lenstar 900
Diagnostic Test: iTrace
Diagnostic Test: Manual caliper measurement
Diagnostic Test: IOL Master 700

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a non-interventional prospective, comparative study of white-to-white, corneal thickness, and anterior chamber depth measurements as taken on the Orbscan II compared to the IOL Master 700 (Zeiss), IOL Master 500 (Zeiss), Atlas 9000 (Zeiss), Lenstar 900 (Haag-Streit), Argos (Alcon), iTrace (Tracey), Pentacam (Oculus), and manual calipers.

Full description

This is a non-interventional prospective, single center, bilateral, comparative study of white-to-white, corneal thickness, and anterior chamber depth measurements as taken on the Orbscan II compared to the IOL Master 700 (Zeiss), IOL Master 500 (Zeiss), Atlas 9000 (Zeiss), Lenstar 900 (Haag-Streit), Argos (Alcon), iTrace (Tracey), Pentacam (Oculus), and manual calipers. Additional biometric devices or external photography may be included as well.

Enrollment

204 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Adults ages 18-50 years of age with healthy eyes and no prior ocular surgery
  2. At least -1.00 of myopia (spherical equivalent)
  3. Able to comprehend and willing to sign informed consent and consent and complete all required testing procedures
  4. Clear intraocular media

Exclusion criteria

  1. Any corneal abnormality, other than regular corneal astigmatism (as determined by pre-operative testing) that in the opinion of the investigator would confound the outcome(s) of the study
  2. History of or current retinal conditions or predisposition to retinal conditions
  3. Amblyopia or strabismus in either eye
  4. History of or current anterior or posterior segment inflammation of any etiology
  5. Any form of neovascularization on or within the eye
  6. Glaucoma (uncontrolled or controlled with medication)
  7. Optic nerve atrophy
  8. Subjects with diagnosed degenerative eye disorders
  9. Subjects who have an acute or chronic disease or illness that would confound the results of this investigation in the opinion of the principal investigator (e.g. connective tissue disease, immunocompromised, clinically significant atopic disease, etc.)

Trial design

204 participants in 1 patient group

Myopic -1.00D
Description:
Myopic patients with a diopter of at least -1.00
Treatment:
Diagnostic Test: IOL Master 700
Diagnostic Test: Manual caliper measurement
Diagnostic Test: iTrace
Diagnostic Test: Lenstar 900
Diagnostic Test: Atlas 9000
Diagnostic Test: Orbscan II
Diagnostic Test: Pentacam
Diagnostic Test: IOL Master 500
Diagnostic Test: Argos

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Diana Hill

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems